Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...

Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. Their research, published in Nature ...

The trimeric pre-fusion glycoprotein F is essential for accurately assessing the immunogenicity of RSV vaccines. We strictly adhere to regulations to provide high-quality, consistent, native ...

GRAND RAPIDS, Mich. — As respiratory syncytial virus (RSV) cases surge, one family's harrowing experience highlights the importance of prevention. Emily and Joey Spadafore watched helplessly as ...